Notice of Results

Futura Medical PLC 18 September 2007 For immediate release 18 September 2007 Futura Medical Plc ('Futura' or 'the Company') Notification of interim results Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for the consumer healthcare market, is pleased to announce that its interim results for the six months ended 30 June 2007 will be announced on Monday 24 September 2007. For any further information please contact: Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 685 670 mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk Canaccord Adams Tel: +44 (0) 20 7050 6500 Mark Ashurst / Erin Needra For any media enquiries please contact: Buchanan Communications Tel: +44 (0) 020 7466 5000 Mark Court / Rebecca Dietrich Notes Futura Medical plc Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange. www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings